{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:09:57Z","timestamp":1795133397585,"version":"4.10.3"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>The aim of this study was to demonstrate the safety and effectiveness of a single TearCare procedure compared with a single LipiFlow procedure in treatment of the dry eye disease associated with meibomian gland dysfunction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In a multicenter, masked, randomized controlled trial, 135 subjects received a single TearCare (TC) treatment (n = 67) or a single LipiFlow (LF) treatment (n = 68) at baseline and were followed up for 1 month posttreatment. Tear film breakup time, meibomian gland function, and corneal and conjunctival staining scores were assessed as dry eye signs at baseline, 2 weeks, and 1 month; dry eye symptoms were assessed using the Ocular Surface Disease Index, Symptom Assessment in Dry Eye, and eye dryness questionnaires at baseline and 1 month.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>At 1 month posttreatment, both groups demonstrated significant improvements (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001) in mean tear film breakup time and meibomian gland secretion score to 3.0 \u00b1 4.4 and 11.2 \u00b1 11.1 in the TC group and 2.6 \u00b1 3.3 and 11.0 \u00b1 10.4 in the LF group, respectively. The mean eye dryness, Symptom Assessment in Dry Eye, and Ocular Surface Disease Index scores were significantly reduced (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001) by 35.4 \u00b1 34.1, 38.2 \u00b1 31.0, and 27.9 \u00b1 20.5 in the TC group and 34.9 \u00b1 26.9, 38.0 \u00b1 25.9, and 23.4 \u00b1 17.7 in the LF group, respectively. There were no statistically significant differences for any result between the groups. However, the TC group demonstrated numerically greater improvements consistently in all signs and symptoms. Device-related ocular adverse events were reported in 3 patients in the TC group (superficial punctate keratitis, chalazion, and blepharitis) and 4 patients in the LF group (blepharitis, 2 cases of foreign body sensation, and severe eye dryness).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>A single TearCare treatment significantly alleviates the signs and symptoms of dry eye disease in patients with meibomian gland dysfunction and is equivalent in its safety and effectiveness profile to LipiFlow treatment as shown in this 1-month follow-up study.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ico.0000000000002837","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T08:11:09Z","timestamp":1632816669000},"page":"417-426","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":35,"title":["TearCare for the Treatment of Meibomian Gland Dysfunction in Adult Patients With Dry Eye Disease: A Masked Randomized Controlled Trial"],"prefix":"10.1097","volume":"41","author":[{"given":"Preeya K.","family":"Gupta","sequence":"first","affiliation":[{"name":"Cornea and Refractive Surgery, Duke University Eye Center, Durham, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Holland","sequence":"additional","affiliation":[{"name":"Cincinnati Eye Institute, Edgewood, KY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hovanesian","sequence":"additional","affiliation":[{"name":"Harvard Eye Associates, Laguna Hills, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Loh","sequence":"additional","affiliation":[{"name":"Loh Ophthalmology Associates, Miami, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell A.","family":"Jackson","sequence":"additional","affiliation":[{"name":"Jacksoneye, Lake Villa, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Karpecki","sequence":"additional","affiliation":[{"name":"Kentucky Eye Institute, Lexington, KY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Dhamdhere","sequence":"additional","affiliation":[{"name":"Sight Sciences, Inc, Menlo Park, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"key":"R1-20250728","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf."},{"key":"R2-20250728","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.survophthal.2011.11.003","article-title":"Evaluation of dry eye","volume":"57","author":"McGinnigle","year":"2012","journal-title":"Surv Ophthalmol."},{"key":"R3-20250728","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","article-title":"The pathophysiology of dry eye disease: what we know and future directions for research","volume":"124","author":"Pflugfelder","year":"2017","journal-title":"Ophthalmology"},{"key":"R4-20250728","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/ICO.0b013e3181f7f363","article-title":"The economic burden of dry eye disease in the United States: a decision tree analysis","volume":"30","author":"Yu","year":"2011","journal-title":"Cornea"},{"key":"R5-20250728","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf."},{"key":"R6-20250728","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1167\/iovs.10-6997b","article-title":"The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee","volume":"52","author":"Nelson","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"R7-20250728","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction","volume":"52","author":"Geerling","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"R8-20250728","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1542-0124(12)70150-7","article-title":"The contribution of meibomian disease to dry eye","volume":"2","author":"Bron","year":"2004","journal-title":"Ocul Surf."},{"key":"R9-20250728","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/ICO.0b013e318225415a","article-title":"Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study","volume":"31","author":"Lemp","year":"2012","journal-title":"Cornea"},{"key":"R10-20250728","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jtos.2019.02.005","article-title":"The optimum temperature for the heat therapy for meibomian gland dysfunction","volume":"17","author":"Borchman","year":"2019","journal-title":"Ocul Surf."},{"key":"R11-20250728","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1167\/iovs.10-6514","article-title":"Human meibum lipid conformation and thermodynamic changes with meibomian-gland dysfunction","volume":"52","author":"Borchman","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"R12-20250728","first-page":"1797","article-title":"Emerging treatment options for meibomian gland dysfunction","volume":"7","author":"Qiao","year":"2013","journal-title":"Clin Ophthalmol."},{"key":"R13-20250728","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/ICO.0b013e3181d836f3","article-title":"Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction","volume":"29","author":"Maskin","year":"2010","journal-title":"Cornea"},{"key":"R14-20250728","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/ICL.0000000000000258","article-title":"Compliance and subjective patient responses to eyelid hygiene","volume":"43","author":"Alghamdi","year":"2017","journal-title":"Eye Contact Lens"},{"key":"R15-20250728","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clae.2016.04.002","article-title":"In-vivo heat retention comparison of eyelid warming masks","volume":"39","author":"Bitton","year":"2016","journal-title":"Cont Lens Anterior Eye."},{"key":"R16-20250728","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/ICL.0000000000000166","article-title":"Long-term (3 year) effects of a single thermal pulsation system treatment on meibomian gland function and dry eye symptoms","volume":"42","author":"Greiner","year":"2016","journal-title":"Eye Contact Lens"},{"key":"R17-20250728","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.2147\/OPTH.S285953","article-title":"A prospective, post-market, multicenter trial (CHEETAH) suggested TearCare system as a safe and effective blink-assisted eyelid device for the treatment of dry eye disease","volume":"14","author":"Karpecki","year":"2020","journal-title":"Clin Ophthalmol."},{"key":"R18-20250728","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/OPTH.S191588","article-title":"TearCare system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare treatment on subjects with dry eye disease","volume":"13","author":"Badawi","year":"2019","journal-title":"Clin Ophthalmol."},{"key":"R19-20250728","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/ICO.0b013e318239aaea","article-title":"A new system, the LipiFlow, for the treatment of meibomian gland dysfunction","volume":"31","author":"Lane","year":"2012","journal-title":"Cornea"},{"key":"R20-20250728","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4140\/TCP.n.2016.96","article-title":"Treatment of dry eye disease","volume":"31","author":"Marshall","year":"2016","journal-title":"Consult Pharm."},{"key":"R21-20250728","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jtos.2017.10.004","article-title":"A simple and cost effective method for preparing FL and LG solutions","volume":"16","author":"Awisi Gyau","year":"2018","journal-title":"Ocul Surf."},{"key":"R22-20250728","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/ICO.0b013e3181814cff","article-title":"Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location","volume":"27","author":"Korb","year":"2008","journal-title":"Cornea"},{"key":"R23-20250728","first-page":"221","article-title":"Report of the national eye institute\/industry workshop on clinical trials in dry eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J."},{"key":"R24-20250728","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1167\/iovs.10-6997f","article-title":"The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee","volume":"52","author":"Tomlinson","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"R25-20250728","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2147\/OPTH.S160403","article-title":"A novel system, TearCare, for the treatment of the signs and symptoms of dry eye disease","volume":"12","author":"Badawi","year":"2018","journal-title":"Clin Ophthalmol."},{"key":"R26-20250728","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/ICO.0000000000002235","article-title":"A 6-week, prospective, randomized, single-masked study of lifitegrast ophthalmic solution 5% versus thermal pulsation procedure for treatment of inflammatory meibomian gland dysfunction","volume":"39","author":"Tauber","year":"2020","journal-title":"Cornea"},{"key":"R27-20250728","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland","volume":"52","author":"Knop","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"R28-20250728","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/cxo.13035","article-title":"Non-pharmaceutical treatment options for meibomian gland dysfunction","volume":"103","author":"Arita","year":"2020","journal-title":"Clin Exp Optom."},{"key":"R29-20250728","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/ICL.0b013e31821bc7c5","article-title":"Meibomian gland therapeutic expression: quantifying the applied pressure and the limitation of resulting pain","volume":"37","author":"Korb","year":"2011","journal-title":"Eye Contact Lens."}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000002837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T22:07:00Z","timestamp":1753740420000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000002837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000002837","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,28]]},"assertion":[{"value":"2021-01-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}